NCT00603941 A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel Status TERMINATED Phase PHASE1/PHASE2
NCT00571519 Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT00570739 Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients. Status COMPLETED Phase PHASE3
NCT00527514 Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension Status COMPLETED Phase PHASE3
NCT00521404 Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00504556 A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT00484419 Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin Status COMPLETED Phase PHASE3
NCT00462761 A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status Status COMPLETED Phase PHASE1
NCT00430950 Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension Status COMPLETED Phase PHASE3
NCT00430638 A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension Status COMPLETED Phase PHASE4
NCT00430508 Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension Status COMPLETED Phase PHASE3
NCT00412932 An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension Status COMPLETED Phase PHASE4
NCT00408434 Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00403481 An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes Status COMPLETED Phase PHASE4
NCT00398216 A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery Status COMPLETED Phase PHASE2
NCT00385944 The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS) Status COMPLETED Phase PHASE2
NCT00382213 A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis Status COMPLETED Phase PHASE3
NCT00361153 Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2